Out of the nearly 1,300 federally filed transvaginal mesh lawsuits, manufacturer Boston Scientific is named in about 170 of them, while manufactures Johnson & Johnson, C.R. Bard, and American Medical Systems have been named in the others. Boston Scientific is also facing over 100 lawsuits filed in Middlesex County, Massachusetts, under Judge Diane Kottmyer. All federally filed vaginal mesh lawsuits have been consolidated in U.S. District Court in Charleston, West Virginia under Judge Joseph R. Goodwin.
Many of the lawsuits question whether the device manufacturers informed the medical community about the potential risks of the implants, and accuse the makers of consistently withholding and under-reporting problems regarding the mesh products to the U.S. Food and Drug Administration, consumers and their physicians.
Though Boston Scientific says they believe the that transvaginal mesh devices remain an important option for the treatment of pelvic organ prolapse and stress urinary incontinence, the FDA has found that the mesh is no more effective then the traditional methods. In fact, the FDA reverse its stance on the use of transvaginal mesh last year, after receiving a high rate of adverse event reports. The agency also reported that nearly 10 percent of women who receive transvaginal mesh as a treatment for POP experience mesh erosion within 12 months of implantation.